Skip to content

HIV acceptance test in cervical dysplasia at the time of colposcopy

HIV acceptance test in cervical dysplasia at the time of colposcop

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20916
Enrollment
750
Registered
2021-03-11
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hiv cervical dysplasie

Interventions

none

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Cytological result PAP 3a1 or higher and / or colposcopic clinical impression of at least CIN I - Able to read / write Dutch / English

Exclusion criteria

Exclusion criteria: - Under 18 years of age - Recent HIV testing (<6months)

Design outcomes

Primary

MeasureTime frame
Acceptance of the HIV rapid test by the patient.

Secondary

MeasureTime frame
Number of positive tests. - Uptake of HIV testing in the various clinics. - Uptake of HIV testing in relation to the severity of the dysplasia. - Feasibility of the HIV rapid test within the current colposcopic setting.

Contacts

Public ContactRalf van de Laar

Erasmus MC

r.vandelaar@erasmusmc.nl0650032145

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)